首页> 美国政府科技报告 >Clinical Trials of Safety and Efficacy of Oral WR 6026 in Treatment of VisceralLeishmaniasis

【24h】

Clinical Trials of Safety and Efficacy of Oral WR 6026 in Treatment of VisceralLeishmaniasis

机译：口服WR 6026治疗内脏利什曼病的安全性和有效性临床试验

获取原文

页面导航

摘要
著录项
相似文献
相关主题

摘要

Under this Cooperative Agreement, the efficacy of an oral 8-aminoquinoline (8.((6-

著录项

作者
Were, J. B.;
展开▼
作者单位

展开▼
年度 1992
页码
总页数 15
原文格式 PDF
正文语种 eng
中图分类工业技术;
关键词
Toxicity; Parasites; Medical services; Leishmaniasis; Oral diseases; Clinicalmedicine; Safety; Adverse conditions; Dosage; Infectious diseases; Africa; Daily occurrence; Language translation; Blood diseases; Methemoglobin; Pharmacology; Oral dosage; Splee;

机译：毒性;寄生虫;医疗服务;利什曼病;口腔疾病;临床医学;安全;不利条件;剂量;传染病;非洲;每日发生;语言翻译;血液病;高铁血红蛋白;药理学;口服剂量; splee;

相似文献

外文文献
中文文献
专利

1. Phase 2 trial of WR6026, an orally administered 8-aminoquinoline, in the treatment of visceral leishmaniasis caused by Leishmania chagasi. [J] . Dietze R, Carvalho SF, Valli LC, The American Journal of Tropical Medicine and Hygiene . 2001,第6期

机译：口服口服的8-氨基喹啉WR6026的2期试验，用于治疗由南美白痢利什曼原虫引起的内脏利什曼病。
2. Long-term treatment response based on severity of Gaudier disease type 1 at baseline after 8 years of treatment with oral eliglustat: Final efficacy and safety results from a phase 2 clinical trial in treatment-naive adult patients [J] . Lau Heather A., Lukina Elena, Watman Nora, Molecular genetics and metabolism . 2018,第2期

机译：基于古斗病疾病的严重程度的长期治疗响应于基线在8年的口腔雄性治疗后的基线：治疗幼稚成年患者的2期临床试验中的最终疗效和安全结果
3. A randomized open label clinical trial to compare the efficacy and safety of intravenous quinine followed by oral malarone vs. intravenous quinine followed by oral quinine in the treatment of severe malaria. [J] . Esamai F, Tenge CN, Ayuo PO, Journal of tropical pediatrics. . 2005,第1期

机译：一项随机开放标签临床试验，比较静脉注射奎宁，口服马拉拉酮与静脉注射奎宁，口服奎宁治疗严重疟疾的疗效和安全性。
4. Effects of an Oral Nutraceutical on Clinical Aspects of Joint Disease in a Blinded, Controlled Clinical Trial: 39 Horses [C] . Kevin G. Keegan, Faith E. Hughes, Tom Lane, Annual Convention of the American Association of Equine Practitioners . 2007

机译：口腔营养法对盲，受控临床试验中联合疾病临床方面的影响：39马
5. Efficacy and safety of novel collagen conduits filled with collagen filaments to treat patients with peripheral nerve injury: A multicenter, controlled, open-label clinical trial [D] . Saeki Masaomi, 佐伯将臣 2019

机译：充满胶原细丝的新型胶原蛋白导管治疗周围神经损伤患者的疗效和安全性：一项多中心，对照，开放标签的临床试验
6. Efficacy and Safety of All-oral 12-week Ravidasvir Plus Ritonavir-boosted Danoprevir and Ribavirin in Treatment-naïve Noncirrhotic HCV Genotype 1 Patients: Results from a Phase 2/3 Clinical Trial in China [O] . Xiaoyuan Xu, Bo Feng, Yujuan Guan, 2019

机译：全口服12周Ravidasvir加上Ritonavir增强的Danoprevir和Ribavirin在未治疗的非肝硬化HCV基因型1患者中的疗效和安全性：来自中国2/3期临床试验的结果
7. Apremilast, an oral phosphodiesterase-4 inhibitor, in the treatment of palmoplantar psoriasis: Results of a pooled analysis from phase II PSOR-005 and phase III Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis (ESTEEM) clinical trials in patients with moderate to severe psoriasis [O] . Bissonnette Robert, Pariser David M., Wasel Norman R., 2016

机译：口服磷酸二酯酶-4抑制剂Apremilast在治疗掌足型牛皮癣中的应用：II期PSOR-005和III期有效性和安全性试验的合并分析结果，评估了Apremilast对银屑病（ESTEEM）在中度患者中的临床试验的效果重度牛皮癣

Clinical Trials of Safety and Efficacy of Oral WR 6026 in Treatment of VisceralLeishmaniasis

摘要

著录项

相似文献

相关主题

期刊订阅